BiotechTube
Advanced Radiation Therapy

Advanced Radiation Therapy

Bedford, United States· Est.
accuboost.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Advanced Radiation Therapy, founded in 2003, is a private company commercializing the AccuBoost platform for accelerated partial breast irradiation (APBI). Its core technology enables non-invasive, image-guided brachytherapy, offering a 5 or 10-day treatment schedule designed to minimize radiation exposure to the heart, lungs, and skin. The company targets the breast cancer radiation therapy market by providing an alternative to both traditional whole-breast irradiation and invasive balloon-based brachytherapy. It operates through a distributor model and is in the commercial stage with its flagship system.

Oncology

Technology Platform

Non-Invasive Image-Guided Breast Brachytherapy (NIBB) using real-time mammographic/tomosynthesis imaging to guide external radiation source placement for targeted breast cancer treatment.

Opportunities

The growing preference for shorter-course APBI and the large patient population with early-stage breast cancer present a significant addressable market.
International expansion through distributor deals, as evidenced by the King Abdullah University Hospital partnership, offers a clear path for growth.
Continued positive clinical data publications can drive increased adoption by key cancer centers.

Risk Factors

Adoption is hindered by the need to change established clinical practices and compete against entrenched radiation therapy technologies.
Long-term clinical outcomes data is still accumulating, and any negative results could impact credibility.
The company's success is highly dependent on securing and maintaining adequate insurance reimbursement for the AccuBoost procedure.

Competitive Landscape

AccuBoost competes in the APBI market against invasive balloon/catheter brachytherapy (e.g., Hologic's Axxent), intraoperative radiation therapy (IORT) systems, and advanced external beam radiotherapy (EBRT) platforms capable of APBI from companies like Varian and Elekta. Its key differentiation is the non-invasive, real-time image-guided approach, but it must convince clinicians of its dosimetric and clinical equivalence or superiority.

More companies in Oncology (General) →More companies in United States →